BIO Ventures for Global Health
BVGH strategically develops and manages programs across the for-profit and non-profit sectors to catalyze innovative research and development (R&D); expand research and healthcare capacity in low- and middle-income countries (LMICs); and increase access to high-quality health care.
Our Programs
African Access Initiative (AAI)
Driven by Africa, for Africa – leveraging public-private partnerships to target the growing cancer crisis.
African Consortium for Cancer Clinical Trials (AC3T)
Building cancer clinical trial capacity in Africa.
Global Innovation Alliance (GIA)
Advancing health equity by reducing the burden of infectious diseases.
“The role of industry in improving global health cannot be understated. We have been, and must continue to be, leaders, experts, innovators, and—most importantly—partners in global efforts to reduce suffering and the burden of disease”
Mr. James Greenwood,
Past President & CEO, Biotechnology Innovation Organization (BIO);
Chairman, BVGH Board of Directors; USA
OUR IMPACT
4000+
Cancer Patients Treated
2500+
Sites Reached
200+
Research Collaborations Established
LATEST NEWS
Bridging the Knowledge Gap: Impact of Community Outreach on Childhood Cancer Awareness and Hospital Navigation in Nigeria
Bridging the Knowledge Gap: Impact of Community Outreach on Childhood Cancer Awareness and Hospital Navigation in Nigeria Contributing Authors: Zainab Shinkafi Bagudu, MBBS, Medicaid Cancer Foundation, Nigeria Maryam Mukhtar Ali, Medicaid Cancer Foundation, Nigeria Micaella Jorge, PhD, BIO Ventures for Global Health, USA Introduction Childhood cancer is an emerging public health concern in many low-resource…
Keep reading
Closing the Cancer Care Gap in Africa
Cancer in AfricaAfrica and other low- and middle-income regions are collectively responsible for 70% of the global cancer burden. Africa faces a 67% mortality-to-incidence ratio from cancer according to recent statistics released by the World Health Organization’s International Agency for Research on Cancer (IARC). Compare this number to the 23% touted by Northern America, and…
Keep reading
Researchers in Germany and Nigeria Join Forces to Differentiate Febrile Diseases with New Diagnostics
In sub-Saharan Africa and other regions with high burdens of malaria, patients presenting with fevers are often prescribed antimalarial drugs without a confirmed diagnosis to avoid treatment delays. However, many infectious diseases cause fevers, and inappropriate use of antimalarial medicines for patients who do not have malaria fuels development of drug resistance. While malaria diagnostic…
Keep reading
Something went wrong. Please refresh the page and/or try again.